Use this URL to cite or link to this record in EThOS:
Title: Skeletal muscle microRNA's in human cancer cachexia and type 2 diabetes
Author: McGregor, Robin A.
ISNI:       0000 0004 2699 1957
Awarding Body: Heriot-Watt University
Current Institution: Heriot-Watt University
Date of Award: 2009
Availability of Full Text:
Access from EThOS:
Access from Institution:
MicroRNAs are powerful post-transcriptional regulators of gene expression and are biomarkers of chronic diseases such as cancer. This thesis explores the role of microRNAs in human cancer cachexia and Type 2 diabetes. MicroRNA expression was measured in skeletal muscle biopsies using RT-qPCR. In pancreatic cancer cachexia patients, expression of microRNA-1, microRNA-133a, microRNA-133b and microRNA-206 was negatively related to weight loss. In Type 2 diabetes skeletal muscle, microRNA-133a and microRNA-206 expression was down-regulated, but there was no evidence of altered microRNA transcription or processing and target expression was unchanged. Importantly, microRNA-133a expression predicted fasting glucose, glucose tolerance and insulin resistance, and therefore may be a biomarker of Type 2 diabetes. Experimental validation of microRNA arrays was unsuccessful in identifying further novel cancer cachexia and Type 2 diabetes microRNA biomarkers. MicroRNA knockdown validated CDC42 and PTBP1 as microRNA-133a targets in myoblasts. In addition, muscle microRNA expression may be regulated by insulin and TNFa. In conclusion, microRNA-133a may be a skeletal muscle biomarker of Type 2 diabetes and cancer cachexia, microRNA-133a responds to extracellular insulin and TNFa, but it remains to be established whether microRNA-133a contributes to cancer cachexia or Type 2 diabetes pathogenesis.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available